SCHEMBL23488283

SCHEMBL23488283

C=CCO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1OC(=O)c1ccc(OCc2ccccc2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 2/20 0.45
LGALS3 P17931 4/20 0.44
LGALS9 O00182 3/20 0.44
LGALS1 P09382 3/20 0.44
LGALS7; LGALS7B P47929 2/20 0.44
LGALS8 O00214 2/20 0.43
SLC6A2 P23975 1/20 0.41
NR4A1 P22736 1/20 0.40
NR4A2 P43354 1/20 0.40
NR4A3 Q92570 1/20 0.40
SLC5A2 P31639 3/20 0.40
SLC5A1 P13866 1/20 0.40
PARP10 Q53GL7 1/20 0.39
NT5E P21589 1/20 0.39
FGF1 P05230 1/20 0.39
FGF2 P09038 1/20 0.39
VEGFA P15692 1/20 0.39
HPSE Q9Y251 1/20 0.39
SRD5A2 P31213 1/20 0.38
LGALS4 P56470 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23488666 1.00 MAOB (0.45) MAOBLGALS3LGALS9LGALS1LGALS7; LGALS7B
SCHEMBL23488160 0.93 LGALS3 (0.48) MAOBLGALS3LGALS9LGALS1LGALS7; LGALS7B
SCHEMBL23488305 0.93 MAOB (0.45) MAOBLGALS3LGALS9LGALS1LGALS7; LGALS7B
SCHEMBL23488264 0.88 SLC6A2 (0.40) MAOBLGALS3LGALS9LGALS1LGALS7; LGALS7B
SCHEMBL23488143 0.85 LGALS8 (0.53) MAOBLGALS3LGALS9LGALS1LGALS7; LGALS7B
SCHEMBL23488412 0.85 LGALS8 (0.53) MAOBLGALS3LGALS9LGALS1LGALS7; LGALS7B
SCHEMBL23488417 0.85 LGALS8 (0.53) MAOBLGALS3LGALS9LGALS1LGALS7; LGALS7B
SCHEMBL19067254 0.82 LGALS3 (0.58) MAOBLGALS3LGALS9LGALS1LGALS7; LGALS7B
SCHEMBL18934785 0.82 LGALS3 (0.58) MAOBLGALS3LGALS9LGALS1LGALS7; LGALS7B
SCHEMBL14819214 0.82 LGALS3 (0.58) MAOBLGALS3LGALS9LGALS1LGALS7; LGALS7B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210170033-A1 NOVEL CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN SANOFI (FR) 2021-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210170033-A1 NOVEL CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN GPR119, SLC2A8, SLC2A4 MAOB 4123/4885LGALS3 156/4885LGALS9 106/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.